ATM and non-small cell lung carcinoma: This study identified the top six canonical pathways dysregulated in NSCLC—i.e., ATM signaling, PI3K/AKT signaling, p53 signaling, PTEN signaling, ERK/MAPK signaling, and EGF signaling.